Wegovy injection is approved for adults to be used with a reduced-calorie diet and increased physical activity for chronic weight management in adult patients.
Patients with a body mass index (BMI) of 30 kg/m2 or greater (obesity) or 27 kg/m2 or greater (overweight)
Patients with weight-related comorbid conditions, such as hypertension (high blood pressure), type 2 diabetes mellitus, or high cholesterol (hyperlipidemia).